Economy

How Analysts Rated Revance Therapeutics, Inc

How Analysts Rated Revance Therapeutics, Inc

Therefore 90% are positive. The stock's 52-week range is $15.85 to $28.75, and its 3-month range is $23.35 to $37.20. They set an "outperform" rating and a $34.00 price target on the stock. Blackrock reported 2.15M shares stake. As per Thursday, July 20, the company rating was initiated by Cantor Fitzgerald.

Revance Therapeutics has one of the best ratings by the Street. Cantor Fitzgerald initiated the shares of RVNC in report on Thursday, July 20 with "Buy" rating. Revance Therapeutics had a negative net margin of 28,187.33% and a negative return on equity of 37.31%. The rating was initiated by Aegis Capital on Tuesday, November 29 with "Buy". The rating was maintained by Suntrust Robinson with "Buy" on Tuesday, June 14. The company was initiated on Monday, November 27 by Barclays Capital. The firm has "Buy" rating by SunTrust given on Thursday, November 2. A sell-side firm might have issued a buy report on the company. It now has negative earnings. Bank of America Corp DE increased its stake in shares of Revance Therapeutics by 29.5% in the first quarter.

Analysts await Sophiris Bio, Inc. (NASDAQ:RVNC). Essex Inv Mgmt Ltd Com reported 124,932 shares. The company's quarterly EPS surprised Wall Street by as much as 9% to the upside in its last earnings announcement, so investors should note this tendency when assessing consensus estimates.

Sabby Management Llc holds 0.05% of its portfolio in Sophiris Bio, Inc. for 357,792 shares. "Separately, CFO, CBO & Secretary SILVERNAIL LAUREN P Sell 10000 shares of the company at a price of $26.83 on 2017-11-07". The California-based Shelton Capital has invested 0.02% in Crown Castle International Corp. Barclays Capital initiated the shares of RVNC in report on Monday, November 27 with "Buy" rating. Franklin Resources Inc. boosted its position in shares of Revance Therapeutics by 13.1% in the second quarter. (NASDAQ:RVNC). Bnp Paribas Arbitrage reported 0% stake. They expect $-0.95 EPS, 0.00% or $0.00 from last year's $-0.95 per share. While in the same Quarter Previous year, the Actual EPS was $-0.95. Of those holders, 40 had increased positions amounting to 1.06 million shares, 39 had decreased positions amounting to 1.15 million shares, and 14 holders have a held position accounting for 25.22 million shares. Its down 0.11, from 1.42 in 2017Q1. Revance Therapeutics, Inc.'s now has a PEG ratio of - where as its P/E ratio is -.

More news: Chance the Rapper Gives Chicago High Schoolers Free Jordans

Several hedge funds have recently added to or reduced their stakes in RVNC. (NASDAQ:RVNC). Schwab Charles Invest Mngmt reported 111,757 shares. Palisade Capital Limited Company Nj accumulated 675,982 shares. 600 were accumulated by Tower Research Cap Limited Company (Trc). Its up 0.64% from 19.11 million shares previously. Ameritas Investment Ptnrs Inc holds 1,969 shares or 0% of its portfolio.

In related news, CEO L Daniel Browne sold 7,600 shares of the company's stock in a transaction that occurred on Wednesday, September 20th. Creative Planning has invested 0% of its portfolio in Revance Therapeutics, Inc. State Of New Jersey Common Pension Fund D has invested 0% in Revance Therapeutics, Inc. (NASDAQ:RVNC). Great West Life Assurance Company Can holds 2,553 shares or 0% of its portfolio. The Massachusetts-based Panagora Asset Mngmt has invested 0% in Revance Therapeutics, Inc.

Guggenheim analyst Rohit Vanjani went through this process and came out today with a very upbeat and promising report on shares of Revance Therapeutics Inc (NASDAQ:RVNC). Prelude Cap Ltd Limited Liability Company holds 16,125 shares. Jennison Assoc Llc owns 378,400 shares. Tiaa Cref Invest Ltd Co, New York-based fund reported 59,509 shares. Moreover, Pnc Ser Group has 0% invested in SM Energy Company (NYSE:SM). The shares were sold at an average price of $24.94, for a total transaction of $189,544.00.

Revance Therapeutics, Inc. (RVNC) has the market capitalization of $1.05 Billion. It has outperformed by 3.70% the S&P500. The company is developing a portfolio of products for aesthetic medicine and underserved therapeutic specialties, including dermatology and neurology. The company's lead drug candidate, DaxibotulinumtoxinA for Injection (RT002), is now in development for the treatment of glabellar lines and cervical dystonia and has the potential to be the first long-acting neurotoxin. Its peptide technology enables delivery of botulinum toxin type A through two investigational drug product candidates, DaxibotulinumtoxinA for Injection (RT002), or RT002 injectable, and DaxibotulinumtoxinA Topical Gel (RT001), or RT001 topical.


  • John Green novel Turtles All the Way Down getting film adaptation

    John Green novel Turtles All the Way Down getting film adaptation

    Turtles All The Way Down , Green's first release in six years, centers on Aza, a 16-year-old with obsessive compulsive disorder. Temple Hill's Isaac Klausner and Marty Bowen will produce, with Erin Siminoff and Molly Saffron overseeing for Fox 2000.

    South Korea's KEPCO picked as preferred bidder for United Kingdom nuclear project

    As such, the financing capabilities of the KEPCO and its consortium partners are expected to hold the key to the future progress. KEPCO plans to use its own April 1400 reactor design, the same that was used in a massive project Korea won in the UAE.
    Mexican acquitted of murder faces gun, immigration charges

    Mexican acquitted of murder faces gun, immigration charges

    Now, he is facing federal firearm charges that carry a maximum penalty of ten years in prison. And on Monday, federal authorities charged him with new immigration and gun violations.
  • Man charged with posting Prince George's photo to aid attack

    Man charged with posting Prince George's photo to aid attack

    The 4-year-old prince, who is third in line to the throne, has royal protection officers with him at all times. Rashid faces two charges of preparing acts of terrorism and assisting others to commit acts of terrorism.
    Doklam detente over? Indian drone 'invaded' our airspace, says China

    Doklam detente over? Indian drone 'invaded' our airspace, says China

    China stakes claim to nearly all of Arunachal Pradesh describing it as part of southern Tibet. The Chinese state media has alleged that an Indian drone invaded its airspace and crashed.

    Alibaba Group (BABA) Receiving Somewhat Favorable Press Coverage, Report Finds

    Alibaba Group accounts for 1.0% of Dai Ichi Life Insurance Company Ltd's portfolio, making the stock its 16th largest position. The stock of Alibaba Group Holding Limited (NYSE: BABA ) earned "Buy" rating by Axiom Capital on Wednesday, October 28.
  • CFPB Employees Form Harry Potter Style Resistance To Trump

    CFPB Employees Form Harry Potter Style Resistance To Trump

    Mulvaney has already brought in Brian Johnson, a former aide to House Financial Services Committee Chairman Rep. The Lower East Side People's Federal Credit Union lawsuit was filed Tuesday in Manhattan federal court.
    Injustice 2: NetherRealm Studios showcases Atom's abilities in new trailer

    Injustice 2: NetherRealm Studios showcases Atom's abilities in new trailer

    Fighter Pack 1 includes Red Hood, Starfire, and Sub-Zero, and Fighter Pack 2 features Black Manta, Raiden, and Hellboy. There are still no details of when the other characters will debut, but we will also see special trailers of them.

    Institutional Investors Are Betting On Corcept Therapeutics Inc (NASDAQ:CORT)

    TheStreet upgraded Corcept Therapeutics from a "c+" rating to a "b" rating in a research report on Friday, March 10th. Piper Jaffray maintained Corcept Therapeutics Incorporated (NASDAQ: CORT ) on Friday, September 8 with "Buy" rating.
  • Jeffrey Tambor Hasn't Exited 'Transparent' Despite Earlier Statement

    Jeffrey Tambor Hasn't Exited 'Transparent' Despite Earlier Statement

    Publicist Allan Mayer offered a more extensive explanation in the wake of more accusations from makeu partist Tamara Delbridge. Tambor is facing an investigation from Amazon over multiple allegations from actresses who say he sexually harassed them.

    Commerzbank Aktiengesellschaft FI Boosts Holdings in Simon Property Group Inc (SPG)

    It has underperformed by 35.26% the S&P500.The move comes after 6 months positive chart setup for the $58.24 billion company. Its up 0.34, from 0.87 in 2017Q1. 628.79 million shares or 0.40% less from 631.34 million shares in 2017Q1 were reported.
    Study confirms higher breast cancer risk with hormone-based contraception

    Study confirms higher breast cancer risk with hormone-based contraception

    Marisa Weiss, an oncologist who founded the website breastcancer.org and was not involved in the study told The New York Times . Overall, there was one extra case of breast cancer for every 7,600 women using hormonal contraception for a year.